|
[1]PARODI A,FISHER D,GIOVANNINI M,et al.Endoscopic management of hilar cholangiocarcinoma[J].Nat Rev Gastroenterol Hepatol,2012,9(2):105-112.
|
|
[2]RAZUMILAVA N,GORES GJ.Cholangiocarcinoma[J].Lancet,2014,383(9935):2168-2179.
|
|
[3] SHARIFF MI,KHAN SA,WESTABY D.The palliation of cholangiocarcinoma[J].Curr Opin Support Palliat Care,2013,7(2):168-174.
|
|
[4]BLECHACZ B,GORES GJ.Cholangiocarcinoma:advances in pathogenesis,diagnosis,and treatment[J].Hepatology,2008,48(1):308-321.
|
|
[5]SMITH AC,DOWSETT JF,RUSSELL RC,et al.Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction[J].Lancet,1994,344(8938):1655-1660.
|
|
[6]DEVIERE J,BAIZE M,DE TJ,et al.Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage[J].Gastrointest Endosc,1988,34(2):95-101.
|
|
[7]de PALMA GD,GALLORO G,SICILIANO S,et al.Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction:results of a prospective,randomized,and controlled study[J].Gastrointest Endosc,2001,53(6):547-553.
|
|
[8]RERKNIMITR R,ANGSUWATCHARAKON P,RATANACHUEK T,et al.Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma[J].J Gastroenterol Hepatol,2013,28(4):593-607.
|
|
[9]HWANG JC,KIM JH,LIM SG,et al.Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction:prospective long-term study[J].Scand J Gastroenterol,2011,46(3):326-332.
|
|
[10]SINGHAL D,van GULIk TM,GOUMA DJ.Palliative management of hilar cholangiocarcinoma[J].Surg Oncol,2005,14(2):59-74.
|
|
[11]FREEMAN ML,SIELAFF TD.A modern approach to malignant hilar biliary obstruction[J].Rev Gastroenterol Disord,2003,3(4):187-201.
|
|
[12]MOSS AC,MORRIS E,LEYDEN J,et al.Do the benefits of metal stents justify the costs?A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction[J].Eur J Gastroenterol Hepatol,2007,19(12):1119-1124.
|
|
[13]RAJU RP,JAGANMOHAN SR,ROSS WA,et al.Optimum palliation of inoperable hilar cholangiocarcinoma:comparative assessment of the efficacy of plastic and self-expanding metal stents[J].Dig Dis Sci,2011,56(5):1557-1564.
|
|
[14]ISAYAMA H,KOMATSU Y,TSUJINO T,et al.A prospective randomised study of‘covered’versus‘uncovered’diamond stents for the management of distal malignant biliary obstruction[J].Gut,2004,53(5):729-734.
|
|
[15]SALEEM A,LEGGETT CL,MURAD MH,et al.Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction[J].Gastrointest Endosc,2011,74(2):321-327.
|
|
[16]PARK DH,SONG TJ,EUM J,et al.EUS-guided hepaticogastrostomy with a fully covered metal stent as the biliary diversion technique for an occluded biliary metal stent after a failed ERCP(with videos)[J].Gastrointest Endosc,2010,71(2):413-419.
|
|
[17]YAMAO K,BHATIA V,MIZUNO N,et al.Interventional endoscopic ultrasonography[J].J Gastroenterol Hepatol,2009,24(4):509-519.
|
|
[18]SHARIFF MI,KHAN SA,WESTABY D.The palliation of cholangiocarcinoma[J].Curr Opin Support Palliat Care,2013,7(2):168-174.
|
|
[19]STEEL AW,POSTGATE AJ,KHORSANDI S,et al.Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction[J].Gastrointest Endosc,2011,73(1):149-153.
|
|
[20]XU HX,WANG Y,LU MD,et al.Percutaneous ultrasoundguided thermal ablation for intrahepatic cholangiocarcinoma[J].Br J Radiol,2012,85(1016):1078-1084.
|
|
[21]PARK SY,KIM JH,YOON HJ,et al.Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma[J].Clin Radiol,2011,66(4):322-328.
|
|
[22]KUHLMANN JB,EURINGER W,SPANGENBERG HC,et al.Treatment of unresectable cholangiocarcinoma:conventional transarterial chemoembolization compared with drug eluting beadtransarterial chemoembolization and systemic chemotherapy[J].Eur J Gastroenterol Hepatol,2012,24(4):437-443.
|
|
[23]BERR F.Photodynamic therapy for cholangiocarcinoma[J].Semin Liver Dis,2004,24(2):177-187.
|
|
[24]ORTNER ME,CACA K,BERR F,et al.Successful photodynamic therapy for nonresectable cholangiocarcinoma:a randomized prospective study[J].Gastroenterology,2003,125(5):1355-1363.
|
|
[25]NOWIS D,STOKLOSA T,LEQAT M,et al.The influence of photodynamic therapy on the immune response[J].Photodiag photodyn Ther,2005,2(4):283.
|
|
[26]ISAYAMA H,TSUJINO T,NAKAI Y,et al.Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma[J].World J Gastroenterol,2012,18(19):2364-2370.
|
|
[27]GERHARDS MF,van GULIK TM,GONZA'LEZ GONZA'LEZ D,et al.Result of postoperative radiotherapy for resectable hilar cholangiocarcinoma[J].World Surg,2003,27(2):173-179.
|
|
[28]ZHU HD,GUO JH,Zh U GY,et al.A novel biliary stent loaded with(125)I seeds in patients with malignant biliary obstruction:preliminary results versus a conventional biliary stent[J].J Hepatol,2012,56(5):1104-1111.
|
|
[29]VALLE J,WASAN H,PALMER DH,et al.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J].N Engl J Med,2010,362(14):1273-1281.
|
|
[30]CHEN JS,HSU C,CHIANG NJ,et al.AKRAS mutation statusstratified randomized phase II trial ofgemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer[J].Ann Oncol,2015,26(5):943-949.
|
|
[31]MARKS EI,YEE NS.Immunotherapeutic approaches in biliary tract carcinoma:Current status and emerging strategies[J].World J Gastrointest Oncol,2015,7(11):338-346.
|
|
[32]KOIDO S,KAN S,YOSHIDA K,et al.Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy[J].Anticancer Res,2014,34(11):6353-6361.
|
|
[33]ARUGA A,TAKESHITA N,KOTERA Y,et al.Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer[J].J Transl Med,2014,12(1):1-11.
|
DownLoad: